A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis.
about
SIRT6 protects against endothelial dysfunction and atherosclerosis in miceNanomedicines for dysfunctional macrophage-associated diseases.Tannic acid as a plant-derived polyphenol exerts vasoprotection via enhancing KLF2 expression in endothelial cells.Icariin, an Anti-atherosclerotic Drug from Chinese Medicinal Herb Horny Goat Weed.Suberanilohydroxamic Acid as a Pharmacological Kruppel-Like Factor 2 Activator That Represses Vascular Inflammation and Atherosclerosis.Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects.
P2860
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis.
@en
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis.
@nl
type
label
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis.
@en
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis.
@nl
prefLabel
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis.
@en
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis.
@nl
P2093
P2860
P356
P1433
P1476
A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis.
@en
P2093
Craig N Morrell
David X Zhang
Marina Koroleva
Meimei Yin
Michael Mastrangelo
Zheng Gen Jin
P2860
P304
37622-37635
P356
10.18632/ONCOTARGET.9376
P407
P577
2016-05-14T00:00:00Z